<DOC>
	<DOCNO>NCT01134237</DOCNO>
	<brief_summary>Intrapleural thrombolytic treatment urokinase retain hemothorax effective safe . However , previous study limit prospective observation study without control group .</brief_summary>
	<brief_title>Intrapleural Urokinase Retained Hemothorax</brief_title>
	<detailed_description>We recruit 32 patient study . The patient retain hemothorax randomly divide urokinase group placebo group . In urokinase group , urokinase 100,000 IU 100 mL NaCl inject intrapleural space . We record daily drainage amount evaluate therapeutic effect chest X-ray . The therapeutic effect , safety , hospital stay , medical cost two group compare . This study do four medical center northern Taiwan .</detailed_description>
	<mesh_term>Hemothorax</mesh_term>
	<criteria>1 . Retained hemothorax : define chest Xray reveal obvious blood clot pleural cavity tube thoracostomy drainage 3 day . The chest tubes good location obstruction . The physician think blood clot difficult drain . 2 . Age : full 18 yearold 1 . Pregnancy 2 . Active bleed 3 . Coagulopathy , e.g . congenital acquire coagulation abnormality , platelet count le 100,000 /Î¼L , international normalize ratio ( INR ) 1.5 , partial thromboplastin time , PTT , 50 second treatment . 4 . Cerebrovascular accident within 30 day 5 . History intracranial tumor vascular abnormality 6 . Have receive thoracic surgery 7 . Have receive pleurodesis 8 . Wish receive thoracoscopic surgery hematoma evacuation directly 9 . Allergy urokinase 10 . Sepsis 11 . Shock 12 . People le 18 year age , prisoner , aborigine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>non-surgical rate</keyword>
</DOC>